Conserved Sequences in a Class of Rare Eukaryotic Nuclear Introns with Non-consensus Splice Sites
Overview
Molecular Biology
Authors
Affiliations
Eukaryotic nuclear genomes contain a rare class of pre-mRNA introns with consensus sequence features that differ markedly from most pre-mRNA introns. Four genes have so far been identified that contain one copy each of this rare intron class in addition to several standard introns. These introns and homologous introns from several species were compared to identify conserved sequence elements and to establish consensus sequences for these elements. The only well-conserved elements are found at the 5' and 3' ends of the introns. The 5' splice site sequence is ATATCCTT beginning with the first nucleotide of the intron and is invariant in the introns examined to date. The 3' splice site consensus sequence is YCCAC ending at the last nucleotide of the intron. An almost invariant sequence of TCCTTAAC is also found near the 3' end of the intron (the 3' upstream element). The length of the introns varies between 95 and 2940 nucleotides. The sequence organization of these introns suggests that they represent a variant class of pre-mRNA introns that might be spliced via a spliceosome mechanism employing factors distinct from those used by other pre-mRNA introns. A search of small nuclear RNA (snRNA) sequences for regions complementary to the conserved elements of this rare class of introns found a strong match between U12 snRNA and the 3' upstream element and a weaker match between U11 snRNA and the 5' splice site sequence.
A guide to the biogenesis and functions of endogenous small non-coding RNAs in animals.
Jouravleva K, Zamore P Nat Rev Mol Cell Biol. 2025; .
PMID: 39856370 DOI: 10.1038/s41580-024-00818-9.
Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies.
Temaj G, Chichiarelli S, Saha S, Telkoparan-Akillilar P, Nuhii N, Hadziselimovic R Hematol Rep. 2024; 16(4):682-697.
PMID: 39584923 PMC: 11587037. DOI: 10.3390/hematolrep16040066.
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis.
Maul-Newby H, Halene S Exp Hematol. 2024; 140():104655.
PMID: 39393608 PMC: 11732257. DOI: 10.1016/j.exphem.2024.104655.
Alternative splicing in prostate cancer progression and therapeutic resistance.
Rawat C, Heemers H Oncogene. 2024; 43(22):1655-1668.
PMID: 38658776 PMC: 11136669. DOI: 10.1038/s41388-024-03036-x.
Kwon Y, Jin S, Song H Nucleic Acids Res. 2023; 52(3):1420-1434.
PMID: 38088204 PMC: 10853781. DOI: 10.1093/nar/gkad1180.